Cuba develops a new cancer treatment drug

Director of Cuba's Labiofam Research Institute Jose Antonio Castro announced that the scientists are developing with a positive result that a new cancer treatment drug can destroy malignant cells but not cause Harmful to surrounding healthy cells.

This anti-cancer compound is extracted from the RJLB14 peptide mixture and has been strictly tested by various detoxifying and pharmacological methods.

Research results on mice in laboratories in Cuba and Europe showed that malignant tumors diminished after injection of the RJLB14 peptide mixture.

In the coming time, Labiofam will present the results to specialized agencies and if approved, this drug will be clinically tested on humans.

According to Castro, this is a compound that can penetrate the pathogens or necrotic cells. Previous types of cancer treatment compounds often inhibit the growth and destruction of disease-carrying cells but also destroy benign cells.

Test results show that this compound reacts well to breast, lung, brain and prostate cancer cells. Mr Castro said the new finding could also contribute to the treatment of a number of other diseases that the international scientific community is very interested in such as AIDS and diabetes.

Cuba's Ministry of Health said cancer accounts for 25% of deaths in the island nation, of which 59% of cancer patients are under 75 years of age.

In 2012, for the first time, cancer became the highest cause of death in Cuba, followed by cardiovascular diseases.